Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro

Latency-reversing agents (LRAs) are considered a potential tool to cure human immunodeficiency virus type 1 (HIV-1) infection, but when they are taken alone, virus production by reactivated cells and subsequent infection will occur. Hence, it is crucial to simultaneously take appropriate measures to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Microbiol
Main Authors: Hattori, Shin-ichiro, Matsuda, Kouki, Tsuchiya, Kiyoto, Gatanaga, Hiroyuki, Oka, Shinichi, Yoshimura, Kazuhisa, Mitsuya, Hiroaki, Maeda, Kenji
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Microbiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6156138/
https://ncbi.nlm.nih.gov/pubmed/30283406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2018.02022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados